Results 261 to 270 of about 163,596 (354)

High Remission Rate in Eosinophilic Chronic Rhinosinusitis Following More Than Two Years of Dupilumab Therapy

open access: yesLaryngoscope Investigative Otolaryngology, Volume 10, Issue 6, December 2025.
ABSTRACT Objective This study aimed to evaluate the clinical remission rate and changes in medication use in patients with eosinophilic chronic rhinosinusitis (ECRS) treated with dupilumab for > 2 years. Methods This retrospective study included 19 patients with ECRS who received dupilumab therapy for > 2 years. The nasal polyp, Lund–Mackay on sinus CT,
Seiichiro Kamimura   +4 more
wiley   +1 more source

External Otitis

open access: yesInternational Journal of Clinical Practice, 1959
openaire   +2 more sources

Transoral Approach for Balloon Dilation of the Eustachian Tube

open access: yesLaryngoscope Investigative Otolaryngology, Volume 10, Issue 6, December 2025.
In patients with challenging nasal or Eustachian tube anatomy, the transnasal approach for balloon dilation of the Eustachian tube (BDET) may be unsuccessful. We describe a transoral technique for BDET that bypasses obstructive nasal anatomy and offers greater flexibility in catheter angulation. This approach may serve as a useful alternative in select
Jared Zhao, Bryan K. Ward
wiley   +1 more source

Infectious Triggers and Immune Dynamics in Guillain–Barré Syndrome: Revisiting Campylobacter jejuni and the Silent Role of Haemophilus influenzae

open access: yesMicrobiologyOpen, Volume 14, Issue 6, December 2025.
Schematic representation of the gut‐brain axis and microbial triggers in Guillain–Barré Syndrome. Post‐infectious immune responses, particularly through molecular mimicry by pathogens, such as Campylobacter jejuni and Haemophilus influenzae, lead to demyelination and subsequent neuromuscular paralysis.
Aswathi Ramesh   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy